Genmab A/S
(GMAB - NASDAQ)
33,60 USD
📋 Profilo Aziendale

Genmab A/S, a biopharmaceutical company founded in 1999 and headquartered in Copenhagen, Denmark, specializes in the discovery and development of innovative antibody therapies primarily for treating cancer and various other serious illnesses.

|